A Large-Scale, Stratified Genetic Analysis of the Major Histocompatibility Complex Region in Early- and Late-Onset Psoriasis in China
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Psoriasis vulgaris is a chronic inflammatory skin disease which occur at any age. It can be clinically classified into two age-onset subtypes: early-onset psoriasis (EOP; ＜40 years) and late-onset psoriasis (LOP; ≥40 years). More evidence showed EOP and LOP have different genetic architecture, notably the risk allele human leukocyte antigen (HLA)-C*06:02 located within the major histocompatibility complex (MHC) region, which was reported to be the outstanding variant associated with EOP. However, genetic structure of EOP and LOP have not been fully elucidated. Objective: To investigated HLA genetic heterogeneity between EOP and LOP in China. Methods: We first calculated the MHC-based heritability of EOP and LOP respectively. Then, we conducted a large-scale, stratified analysis including 7,097 EOP, 1,337 LOP patients, and 9,906 healthy controls by using MHC target sequencing data from a previous study. Results: We observed that HLA alleles collectively explained a larger heritability of EOP (27.4%) than LOP (11.3%). Further association analysis identified three independent loci (HLA-C*01:02, p=6.70×10−8; HLA-A amino acid position 9, p=3.27×10−17; and HLA-A amino acid position 161, p=5.75×10−10) that confer specific susceptibility to EOP. Our data also confirmed HLA-C*06:02 as an independent psoriasis-associated variant, contributing a higher degree of risk to EOP than LOP. Moreover, case-case analysis confirmed that HLA-C*06:02-positive psoriasis patients have earlier onset. Conclusion: Our analysis indicating that different genetic background underlie the EOP and LOP. We believe these findings will serve to predict psoriasis risk in the future and facilitate clinical decision.
Abstract
Background: Psoriasis vulgaris is a chronic inflammatory skin disease which occur at any age. It can be clinically classified into two age-onset subtypes: early-onset psoriasis (EOP; ＜40 years) and late-onset psoriasis (LOP; ≥40 years). More evidence showed EOP and LOP have different genetic architecture, notably the risk allele human leukocyte antigen (HLA)-C*06:02 located within the major histocompatibility complex (MHC) region, which was reported to be the outstanding variant associated with EOP. However, genetic structure of EOP and LOP have not been fully elucidated. Objective: To investigated HLA genetic heterogeneity between EOP and LOP in China. Methods: We first calculated the MHC-based heritability of EOP and LOP respectively. Then, we conducted a large-scale, stratified analysis including 7,097 EOP, 1,337 LOP patients, and 9,906 healthy controls by using MHC target sequencing data from a previous study. Results: We observed that HLA alleles collectively explained a larger heritability of EOP (27.4%) than LOP (11.3%). Further association analysis identified three independent loci (HLA-C*01:02, p=6.70×10−8; HLA-A amino acid position 9, p=3.27×10−17; and HLA-A amino acid position 161, p=5.75×10−10) that confer specific susceptibility to EOP. Our data also confirmed HLA-C*06:02 as an independent psoriasis-associated variant, contributing a higher degree of risk to EOP than LOP. Moreover, case-case analysis confirmed that HLA-C*06:02-positive psoriasis patients have earlier onset. Conclusion: Our analysis indicating that different genetic background underlie the EOP and LOP. We believe these findings will serve to predict psoriasis risk in the future and facilitate clinical decision.
참고문헌 (25)
- Henseler T, "Psoriasis of early and late onset : characterization of two types of psoriasis vulgaris", J Am Acad Dermatol, 13, pp.450~456 (1985)
- Zhang X, "The genetic epidemiology of psoriasis vulgaris in Chinese Han", Int J Dermatol, 41, pp.663~669 (2002)
- Theodorakopoulou E, "Early-and late-onset psoriasis : a cross-sectional clinical and immunocytochemical investigation", Br J Dermatol, 175, pp.1038~1044 (2016)
- Russell TJ, "Histocompatibility(HL-A)antigens associated with psoriasis", N Engl J Med, 287, pp.738~740 (1972)
- Nair RP, "Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene", Am J Hum Genet, 78, pp.827~851 (2006)
- Zhang XJ, "Evidence for a major psoriasis susceptibility locus at 6p21(PSORS1)and a novel candidate region at 4q31 by genomewide scan in Chinese hans", J Invest Dermatol, 119, pp.1361~1366 (2002)
- Fan X, "Fine mapping of the psoriasis susceptibility locus PSORS1supports HLA-C as the susceptibility gene in the Han Chinese population", PLoS Genet, 4, pp.e1000038~ (2008)
- Zhang XJ, "Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21", Nat Genet, 41, pp.205~210 (2009)
- Zhou F, "Deep sequencing of the MHC region in the Chinese population contributes to studies of complex disease", Nat Genet, 48, pp.740~746 (2016)
- Ye L, "Genetic factors are stressed variably by onset age-based sample selection in psoriasis: a hint from major histocompatibility complex region-based analysis", J Gene Med, 19, pp.e2997~ (2017)
- Gudjonsson JE, "Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C-and HLA-B-typed patients", J Invest Dermatol, 126, pp.740~745 (2006)
- Yang J, "GCTA : a tool for genome-wide complex trait analysis", Am J Hum Genet, 88, pp.76~82 (2011)
- Ding X, "Prevalence of psoriasis in China : a population-based study in six cities", Eur J Dermatol, 22, pp.663~667 (2012)
- Chang CC, "Second-generation PLINK : rising to the challenge of larger and richer datasets", Gigascience, 4, pp.7~ (2015)
- Humphrey W, "VMD : visual molecular dynamics", J Mol Graph, 14, pp.33~38 (1996)
- Blicher T, "High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide", Acta Crystallogr D Biol Crystallogr, 61(Pt 8), pp.1031~1040 (2005)
- Mallon E, "HLA-CW*0602 is a susceptibility factor in type I psoriasis, and evidence Ala-73 is increased in male type I psoriatics", J Invest Dermatol, 109, pp.183~186 (1997)
- Cai M, "HLA-C*01 : 02 and HLA-A*02 : 07 confer risk specific for psoriatic patients in Southern China", J Invest Dermatol, 139, pp.2045~2048 (2019)
- Allen MH, "The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis", J Invest Dermatol, 124, pp.103~106 (2005)
- Szczerkowska-Dobosz A, "Lack of association of HLA-C alleles with late-onset psoriasis in the northern Polish population", J Appl Genet, 48, pp.273~275 (2007)
- Mabuchi T, "HLA-C*12 : 02 is a susceptibility factor in late-onset type of psoriasis in Japanese", J Dermatol, 41, pp.697~704 (2014)
- "Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia", Biol Psychiatry, 72, pp.620~628 (2012)
- Prinz JC, "Human leukocyte antigen-class I alleles and the autoreactive T cell response in psoriasis pathogenesis", Front Immunol, 9, pp.954~ (2018)
- Arakawa A, "Melanocyte antigen triggers autoimmunity in human psoriasis", J Exp Med, 212, pp.2203~2212 (2015)
- Biral AC, "Association of HLA-A, -B, -C genes and TNF microsatellite polymorphism with psoriasis vulgaris:a study of genetic risk in Brazilian patients", Eur J Dermatol, 16, pp.523~529 (2006)